Hello, Fool! | Login | Signup | My Fool
Dec 5, 2008 2:40 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.
View All Commentary (CVTX)
Recs
Elisaiah (65.52) Submitted: 7/17/08 8:54 PM : Start Price: $8.54 CVTX Score: 37.94
Management finally getting it together; costs in line with revenue and drug pipeline looks promising. Maybe a takeover target....
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK